SLC7A11 and cancer: The results showed that SLC7A11 expression is negatively associated with CD8+ T-cell infiltration in seven cancers (DLBC, ESCA, HNSC, LUAD, LUSC, TGCT, and THCA), suggesting the combination of ferroptosis induction and immunotherapy may be suitable in these cancers’ treatment (Supplementary Figure S3).